Is EINECS 265-829-4 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 265-829-4? Is EINECS 265-829-4 safe for nursing mother and child? Does EINECS 265-829-4 extracts into breast milk? Does EINECS 265-829-4 has any long term or short term side effects on infants? Can EINECS 265-829-4 influence milk supply or can EINECS 265-829-4 decrease milk supply in lactating mothers?
EINECS 265-829-4 lactation summary
- DrLact safety Score for EINECS 265-829-4 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EINECS 265-829-4 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 265-829-4 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EINECS 265-829-4 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EINECS 265-829-4 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 265-829-4 usage in lactation
On latest update relevant data on breastfeeding was not found. Its high molecular weight and plasma protein binding make excretion into breast milk unlikely as has been shown for other related anti-psychotic compounds.
Answer by DrLact: About EINECS 265-829-4 usage in lactation
Because no information is available on the use of EINECS 265-829-4 during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
EINECS 265-829-4 Possible Effects in Breastfeeding
Galactorrhea has been reported with EINECS 265-829-4.[1] Hyperprolactinemia appears to be the cause of the galactorrhea. The hyperprolactinemia is caused by the drug's dopamine-blocking action in the tuberoinfundibular pathway. The maternal prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Quetiapine(Safe)
Pimozide(Unsafe)
Perphenazine(Safe)
Olanzapine(Safe)
Flupenthixol(Safe)
Zuclopenthixol(Safe)
Mesoridazine(Unsafe)
Loxapine(Unsafe)
Asenapine(Low Risk)
Haloperidol(Safe)
Droperidol(Low Risk)
Fluphenazine(Low Risk)
Paliperidone(Safe)
Clozapine(Low Risk)
Sulpiride(Safe)
Chlorpromazine(Low Risk)
Ziprasidone(Unsafe)
Aripiprazole(Low Risk)
Trifluoperazine(Safe)
Thiothixene(Unsafe)
Thioridazine(Unsafe)
Risperidone(Safe)